Published in Clin Radiol on January 01, 1981
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases. Br J Cancer (1997) 2.18
Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer (1995) 2.04
Extramedullary plasmacytomas in the head and neck region. Eur Arch Otorhinolaryngol (2008) 1.33
Endoscopic endonasal transsphenoidal resection of solitary extramedullary plasmacytoma in the sphenoid sinus with destruction of skull base. J Korean Neurosurg Soc (2009) 0.85
Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study. World J Radiol (2013) 0.75
Establishment of an innovative staging system for extramedullary plasmacytoma. BMC Cancer (2016) 0.75
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med (1997) 7.61
Growth characteristics of a mouse plasma cell tumor. Cancer Res (1968) 2.80
Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol (1983) 2.71
Kaposi's sarcoma in recipients of renal transplants. Am J Med (1979) 2.45
Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst (1971) 2.17
The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. N Engl J Med (1979) 1.86
Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys (1992) 1.45
Melphalan therapy for plasma cell myeloma. Blood (1968) 1.43
The influence of chemotherapy on the management of non-Hodgkin's lymphomata at the Princess Margaret Hospital. A comparison of the results from 1962-64 with 1967-69. Br J Cancer Suppl (1975) 1.35
The treatment of plasma cell myeloma. Adv Cancer Res (1967) 1.30
An assessment of massive-dose chemotherapy of malignant disease. Can Med Assoc J (1971) 1.29
Radiotherapy of chondrosarcoma of bone. Cancer (1980) 1.26
Mesenchymal chondrosarcoma: a report of 17 cases. Clin Orthop Relat Res (1981) 1.26
Chemotherapy of mouse myeloma: quantitative cell cultures predictive of response in vivo. Blood (1973) 1.22
Ameloblastoma of the jaw. A reappraisal of the role of megavoltage irradiation. Cancer (1984) 1.12
Plasma cell neoplasms and acute leukaemia. Clin Haematol (1982) 1.11
Radiotherapy for unusual tumors of the head and neck. J Otolaryngol (1984) 1.10
Histopathological study of radionecrosis in laryngeal carcinoma. Laryngoscope (1982) 1.09
The chronic leukemias: a review of disease manifestations and the aims of therapy. Can Med Assoc J (1967) 1.07
Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271). Cancer Chemother Rep (1976) 1.07
Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Cancer (1972) 1.04
Management of T3 glottic cancer. Arch Otolaryngol (1980) 1.02
Kappa and lambda light chain disease: survival rates and clinical manifestations. Blood (1976) 1.01
Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys (1978) 1.00
The treatment of glomus tumors in the temporal bone by megavoltage radiation. Cancer (1984) 0.97
Radiotherapy for malignant melanoma: a re-appraisal. Cancer Treat Rev (1981) 0.96
Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses. Can Med Assoc J (1968) 0.96
Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide. Can Med Assoc J (1972) 0.96
Postirradiation sarcoma of bone: a perspective. Cancer (1979) 0.95
Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol (1985) 0.94
Sarcoma and Cystosarcoma phyllodes tumors of the breast--a retrospective review of 58 cases. Am J Surg (1994) 0.94
Supervoltage irradiation in the management of giant cell tumor of bone. Radiology (1977) 0.93
Prognostic significance of thyroid gland involvement in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg (1986) 0.92
Second primary respiratory tract malignancies in glottic carcinoma. Cancer (1980) 0.92
Radical external beam radiation therapy for adenocarcinoma of the rectum. Dis Colon Rectum (1983) 0.92
Treatment of plasma cell myeloma with cytotoxic agents. Arch Intern Med (1975) 0.91
Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Cancer Chemother Rep (1971) 0.91
Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve. Arch Otolaryngol (1983) 0.91
Controversies in the treatment of plasma cell myeloma. Postgrad Med J (1985) 0.90
Effect of daily etidronate on the osteolysis of multiple myeloma. J Clin Oncol (1991) 0.90
Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys (1983) 0.90
Second primary respiratory tract malignant neoplasms in supraglottic carcinoma. Arch Otolaryngol (1981) 0.90
Hypertrichosis lanuginosa acquisita associated with adenocarcinoma of the lung. Can Med Assoc J (1982) 0.89
Results of radical radiation for chondrosarcoma of bone. Radiother Oncol (1983) 0.89
The treatment of chordomas. Cancer Treat Rev (1982) 0.89
Differential effects of melphalan on mouse myeloma (adj. PC-5) and hemopoietic stem cells. Cancer Res (1971) 0.88
Radiotherapy of Kaposi's sarcoma. Cancer (1978) 0.87
Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys (1982) 0.87
Ascorbic acid: a culture requirement for colony formation by mouse plasmacytoma cells. Science (1971) 0.87
Multiple gingival metastases from angiosarcoma of the breast. Oral Surg Oral Med Oral Pathol (1987) 0.86
Results of treating Hodgkin's disease without a policy of laparotomy staging. Cancer Treat Rep (1982) 0.86
Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. Can Med Assoc J (1972) 0.86
Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol (1985) 0.85
Supervoltage radiotherapy in the treatment of difficult giant cell tumors of bone. Clin Orthop Relat Res (1983) 0.85
Radiotherapy of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys (1986) 0.85
Breast cancer after treatment for osteosarcoma. Med Pediatr Oncol (1986) 0.85
Squamous cell carcinoma of the bronchus associated with hypercalcemia in a twenty-year-old. Cancer (1981) 0.85
The quality of life of patients following treatment for laryngeal cancer. Int J Radiat Oncol Biol Phys (1983) 0.83
Primary radiation therapy in the treatment of anal canal carcinoma. Dis Colon Rectum (1983) 0.83
Bone marrow transplantation in patients with acute leukaemia. Ser Haematol (1972) 0.83
The place of radiotherapy in the treatment of synovial sarcoma. Int J Radiat Oncol Biol Phys (1981) 0.82
Verrucous carcinoma of the ear. Case report. Ann Otol Rhinol Laryngol (1984) 0.82
Linear analogue self-assessment of voice quality in laryngeal cancer. J Chronic Dis (1984) 0.82
Plasma cell myeloma. An interpretive review. Cancer (1972) 0.81
A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Br J Cancer Suppl (1975) 0.81
Intravenous catheter infection study: a prospective trial in patients with neoplastic disease. Med Pediatr Oncol (1975) 0.81
Total body irradiation for myelomatosis. Br Med J (1971) 0.81
Postoperative local abdominal irradiation for cancer of the colon above the peritoneal reflection. Int J Radiat Oncol Biol Phys (1985) 0.81
T4NOMO glottic cancer: an analysis of dose-time volume factors. Int J Radiat Oncol Biol Phys (1981) 0.80
Computed tomography of retroperitoneal and mesenteric sarcomas: a pictorial essay. Can Assoc Radiol J (1996) 0.80
Sensitivity of human and murine hemopoietic precursor cells to chemotherapeutic agents assessed in cell culture. Blood (1973) 0.79
Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer. Ann Oncol (1992) 0.79
Total abdominal irradiation for cancer of the colon. Radiother Oncol (1984) 0.79
T2 glottic cancer: an analysis of dose-time-volume factors. Int J Radiat Oncol Biol Phys (1981) 0.79
Kaposi's sarcoma. An update on the results of extended field radiotherapy. Arch Dermatol (1981) 0.79
Radiotherapy in nonlentiginous melanoma of the head and neck. Cancer (1981) 0.79
Radiotherapy of early glottic cancer--I. Int J Radiat Oncol Biol Phys (1979) 0.79
Review of bone marrow transplants at the Ontario Cancer Institute. Transplant Proc (1971) 0.79
Myeloma, melphalan, and meta-analysis. J Clin Oncol (1992) 0.78
Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria. Can Med Assoc J (1975) 0.78
Cancer of the tonsil: results of radical radiation therapy with surgery in reserve. Am J Surg (1983) 0.78
Staging and the evaluation of prognosis for patients with small-cell carcinoma of the lung. J Clin Oncol (1986) 0.78
Colony growth and self renewal of plasma cell precursors in multiple myeloma. J Clin Oncol (1985) 0.78
Interferons in the treatment of multiple myeloma. J Clin Oncol (1990) 0.78
Radiotherapy of early glottic cancer--II. Int J Radiat Oncol Biol Phys (1979) 0.78
Radiation therapy in clinical stage I and II Hodgkin's disease. The Princess Margaret Hospital Lymphoma Group. Eur J Cancer (1992) 0.77
Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys (1983) 0.77
Verrucous carcinoma (Ackerman's tumor) of the larynx: diagnostic and therapeutic considerations. Head Neck Surg (1987) 0.77
0-7-21 radiotherapy in nodular melanoma. Cancer (1983) 0.77
Carcinoma of the hypopharynx results of primary radical radiation therapy. Int J Radiat Oncol Biol Phys (1983) 0.77
An atypical immunoglobulin. Blood (1968) 0.77
Determination of IL6, IL1, and IL4 in the plasma of patients with multiple myeloma. Leuk Lymphoma (1994) 0.77
Primary subglottic carcinoma masquerading clinically as T1 glottic carcinoma--a report of nine cases. J Otolaryngol (1985) 0.77
Management of advanced glottic cancer. A 10 year review of the Toronto experience. Int J Radiat Oncol Biol Phys (1979) 0.77
Treatment of plasma cell myeloma. Annu Rev Med (1979) 0.77
Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia. Can Med Assoc J (1977) 0.77
Carcinoma of the tonsil: the effect of dose-time-volume factors on local control. Int J Radiat Oncol Biol Phys (1985) 0.76
Radiation therapy for melanomas of the head and neck. Head Neck Surg (1982) 0.76